Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
1R29CA070337-01
Application #
2114245
Study Section
Experimental Immunology Study Section (EI)
Project Start
1996-04-01
Project End
1996-11-15
Budget Start
1996-04-01
Budget End
1996-11-15
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
074615394
City
Houston
State
TX
Country
United States
Zip Code
77030
Meseck, Marcia; Huang, Tiangui; Ma, Ge et al. (2011) A functional recombinant human 4-1BB ligand for immune costimulatory therapy of cancer. J Immunother 34:175-82
Yin, Bingjiao; Ma, Ge; Yen, Chun-Yu et al. (2010) Myeloid-derived suppressor cells prevent type 1 diabetes in murine models. J Immunol 185:5828-34
Qiao, J; Doubrovin, M; Sauter, B V et al. (2002) Tumor-specific transcriptional targeting of suicide gene therapy. Gene Ther 9:168-75
Angel, L P; Divino, C M; Brower, S T et al. (2000) A novel immunocytolytic factor secreted by pancreatic adenocarcinoma. J Surg Res 91:154-8
Kusmartsev, S A; Li, Y; Chen, S H (2000) Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. J Immunol 165:779-85
Chen, S H; Pham-Nguyen, K B; Martinet, O et al. (2000) Rejection of disseminated metastases of colon carcinoma by synergism of IL-12 gene therapy and 4-1BB costimulation. Mol Ther 2:39-46
Divino, C M; Chen, S H; Yang, W et al. (2000) Anti-tumor immunity induced by interleukin-12 gene therapy in a metastatic model of breast cancer is mediated by natural killer cells. Breast Cancer Res Treat 60:129-34
Pham-Nguyen, K B; Yang, W; Saxena, R et al. (1999) Role of NK and T cells in IL-12-induced anti-tumor response against hepatic colon carcinoma. Int J Cancer 81:813-9
Divino, C M; Angel, L P; Brower, S T et al. (1999) Characterization of a novel immunocytolytic factor secreted by pancreatic adenocarcinoma. Oncol Res 11:489-95